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Abstract--Nonhepatic human cell variants resistant to the arginine analog, canavanine, 
express argininosuccinate synthetase (AS) mRNA at levels 200-fold higher than parental cells 
without amplification of  AS gene sequences. In this report we show that this regulation occurs 
in the nucleus prior to polyadenylation of  AS  precursor RNA and occurs through a 
positive-acting mechanism operating in canavanine-resistant cells. The half-life of  cytoplas- 
mic AS  mRNA was estimated by blocking cellular transcription with actinomycin D. In both 
parental and canavanine-resistant variants of  RPM12650 cells, the AS  mRNA decayed with a 
half-life of  12-24 h, showing that cytoplasmic mRNA stabilization was not involved in this 
regulation. Quantification of  AS  RNA following cell fractionation showed that AS  precursor 
RNA was present at greatly elevated amounts in the nuclei of  canavanine-resistant cells. 
Similar results were obtained when nonpolyadenylated RNA was examined. Thus, the 
mechanism underlying high expression of  AS mRNA in canavanine-resistant cells is an early 
nuclear event, and the processes of  polyadenylation and transport of  RNA to the cytoplasm 
are not involved. Intraspecific somatic cell hybrids were constructed to test whether the 
induction of  AS  mRNA was due to a gain of  a function in canavanine-resistant cells or to a loss 
of  a function in parental cells. Quantification of  AS  mRNA in hybrid cell lines showed that 
such cells contained high levels similar to those found in the canavanine-resistant parent. 
These findings show that the induction of  AS  mRNA is due to a positive-acting mechanism 
operating in the nucleus of  canavanine-resistant cells. 
INTRODUCTION 
The human argininosuccinate synthetase 
(AS) gene is subject to two independently 
acting control mechanisms in cultured cells 
(1, 2). In nonhepatic tissues, where it plays a 
role in arginine biosynthesis, AS is expressed 
at relatively low levels as compared to liver. In 
several nonhepatic cell types, AS is subject to 
metabolite-mediated repression by arginine 
(3, 4). In previous reports, we (1) and others 
(2) showed that the bacterial chloramphenicol 
acetyltransferase (CAT) gene under the tran- 
scriptional control of the human AS promoter 
was subject to regulation by arginine. 
The human AS gene is also subject to 
another control mechanism in cultured cells 
that results in high expression of AS mRNA. 
Human cell variants expressing high levels of 
AS can be selected by growth in the presence 
of canavanine, a toxic arginine analog. These 
variants arise at a frequency of about 10 -6 to 
10 7 from the human squamous cell carci- 
noma line, RPMI 2650, and express the AS 
113 
0740-7750/89/0300-0113506.00/0 9 1989 Plenum Publishing Corporation 
114 Boyce and Freytag 
mRNA at levels 200-fold higher than paren- 
tal cells and similar to that in highly differen- 
tiated cell types such as normal human hepa- 
tocytes. This system is unique in that the 
increased expression of AS mRNA in resis- 
tant cells is not due to amplification of AS  
gene sequences (4). Once established, the 
canavanine-resistant phenotype is stable, sug- 
gesting that a genetic or stable epigenetic 
event has occurred in the canavanine-resistant 
cell. 
We have studied AS gene expression in 
canavanine-resistant cell variants, since it is 
possible that the mechanism used to achieve 
high AS mRNA levels might be similar (iden- 
tical) to that used in normal human liver. The 
canavanine-resistant phenotype is selectable, 
thus this system provides a means for the 
cloning of trans-acting loci that activate a 
liver function (high AS gene expression) using 
genomic DNA transfection. Such experi- 
ments are feasible only if a single locus is 
involved and the resulting phenotype is domi- 
nant, implying a gain of a function. In this 
report we show that the 200-fold increased 
expression of AS mRNA occurs through a 
dominant, positive-acting mechanism operat- 
ing in the nucleus of the canavanine-resistant 
cell. 
MATERIALS AND M E T H O D S  
Somatic Cell Hybrids. The parental cell 
lines used for the construction of the somatic 
cell hybrids were RP10C4, a previously 
described G418-resistant RPMI 2650 cell line 
(1), and C6C2, a mycophenolic acid-resistant 
and canavanine-resistant line obtained by 
transfection of Can r-1 cells (4) with RSVgpt 
(5). One day prior to fusions, 1 • 10 6 cells of 
each parent were seeded into a single 35-mm 
dish. Fusions were performed by rinsing cell 
monolayers with phosphate-buffered saline 
(PBS), addition of 1 ml 50% PEG 1500 (poly- 
ethylene glycol, Boehringer Mannheim) for 1 
min, followed by extensive rinsing with PBS 
and replacement of normal growth medium 
(Dulbecco's modified Eagle's medium, 
DMEM, supplemented with 10% fetal calf 
serum). Two days later cells were detached by 
trypsinization and seeded into 100-mm dishes 
containing normal growth medium supple- 
mented with 1 mg/ml G418 (50% active, 
GIBCO), 15 /zg/ml hypoxanthine, 2 #g/ml 
aminopterin, 10 #g/ml thymidine, 25 #g/ml 
mycophenolic acid, and 250 #g/ml xanthine. 
Individual colonies were isolated four weeks 
later using cloning cylinders. 
RNA Isolation and S1 Nuclease As- 
says. Total cellular RNA was isolated using 
the guanidinium isothiocyanate-CsC1 density 
gradient method (6). Polyadenylated RNA 
was isolated by affinity chromatography on 
oligo-dT cellulose as described (6). Nuclear 
and cytoplasmic RNAs were prepared from 
a p p r o x i m a t e l y  10 9 cells as described (6). 
Briefly, cells were harvested in PBS, collected 
by centrifugation at 2000g for 5 min, and 
lysed by mild vortexing in lysis buffer (0.14 M 
NaC1, 1.5 mM MgC12, 10 mM Tris HC1 (pH 
8.6), 0.5% Triton X-100, and 100 mM vana- 
dyl ribonucleotide complex). The nuclei were 
purified by overlay onto lysis buffer contain- 
ing 0.3 M sucrose followed by centrifugation 
at 10,000g for 20 min. The turbid supernatant 
containing cytoplasm was deproteinized by 
digestion with 200 #g/ml proteinase K for 30 
min at 37~ and extracted with phenol/ 
CHC13. Nuclei were lysed by the addition of 
SDS to a final concentration of 1%, genomic 
DNA was sheared by passage through a 21- 
gauge needle, and the extract was deprotein- 
ized as described above. DNA was then 
removed from nuclear samples by digestion 
with 100 units/ml RQ1 DNase for 30 min at 
37~ Oligodeoxynucleotides were removed 
by precipitation in 20% sodium acetate. The 
nuclear RNA was free of ribosomal RNA, 
and the yield was approximately 10% of the 
cytoplasmic yield. S1 nuclease assays were 
performed essentially as previously described 
(7), and [32p]radioactive probes were pre- 
pared using standard procedures. Differences 
between the intensities of two hybridization 
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signals in the autoradiograms were quantified 
by applying serial dilutions of the more 
radioactive sample on the same gel. 
Act inomycin  D Inhibi t ion.  Tran-  
scription was blocked in subconfluent dishes 
(150 mm) of RPMI 2650 and Canr-1 cells (4) 
by the addition of 20 ml of fresh growth 
medium containing 10 #g/ml actinomycin D 
(mannitol salt, Sigma). Cells were harvested 
at specific times thereafter and total cellular 
RNA was prepared. 
RESULTS 
AS Gene is Weakly Transcribed and 
mRNA is Very Stable. Previous studies 
showed that AS promoter-CAT minigenes 
containing approximately 3 kb of AS 5'- 
flanking sequence are not more transcription- 
ally active in canavanine-resistant cells (1, 2). 
Therefore, in order to test for transcriptional 
regulation more directly, we attempted to 
measure AS gene transcription rates in RPMI 
2650 and Can r- 1 cells using nuclear "run-on" 
assays (8, 9). Although we could readily 
detect specific transcription of genes that are 
expressed abundantly in both cell types (actin 
and phosphoglycerate kinase), we were 
repeatedly unsuccessful in detecting AS gene 
transcription using either cDNA or intron 
probes (data not shown). We were able to 
demonstrate that in vitro synthesized AS 
mRNA was detectable in our assays (hybrid- 
ization efficiencies were 15-50%) and that 
background hybridization was low (less than 5 
ppm). Given that the AS mRNA is present at 
about 3 copies per cell in RPMI 2650 cells and 
approximately 500 copies per cell in canavan- 
ine-resistant cells (unpublished observations) 
and that the half-life of the AS mRNA is 
relatively long (see below), it was not surpris- 
ing to find that the AS gene is weakly tran- 
scribed in the cell lines employed in these 
studies. This is consistent with the idea that 
the AS gene is considered a "housekeeping" 
gene in nonhepatic tissue and that tran- 
scription of such genes is often below detec- 
tion in cultured cell lines. For example, tran- 
scription of the dihydrofolate reductase gene, 
another "housekeeping" gene, is detectable 
only in cell lines in which the gene is amplified 
500-fold (10). Since AS gene transcription 
was not measurable in either cell type, we took 
a more indirect approach to examine the 
molecular basis of this regulation. 
The degradation rate of mature AS 
mRNA was estimated by blocking cellular 
gene transcription with actinomycin D, and 
the decay of specific mRNA was monitored 
using quantitative S 1 nuclease assays (Fig. 1). 
The data show that the AS mRNA was very 
stable in both RPMI 2650 and Canr-1 cells 
with a half-life of approximately 12-24 h. The 
observed decay of AS mRNA was not expo- 
nential in either cell line, which is common for 
long-lived mRNAs, and probably reflects 
experimental artifacts when using metabolic 
inhibitors over extended periods of time. 
Although the mRNA half-life appears to be 
slightly longer in the Canr-1 cell line, this 
minor difference (threefold) is not nearly 
enough to account for the 200-fold increased 
levels of AS mRNA in these cells. Based on 
these results, we tentatively concluded that 
the increase in AS mRNA in canavanine- 
resistant cells was not the result of cytoplas- 
mic mRNA stability. This conclusion was 
substantiated by cellular fractionation studies 
(see below). Although total cellular RNA was 
used in this experiment, the majority of the 
cellular AS RNA is mature cytoplasmic 
mRNA (see fractionation experiments be- 
low). Thus, this experiment measures only the 
decay rate of mature cytoplasmic mRNA and 
does not exclude a nuclear RNA stabilization 
or transport effect. 
Elevation of  Argininosuccinate Synthe- 
tase Precursor RNA Levels in Canavanine- 
Resistant Cell Nuclei. The mRNA decay 
experiments described above suggested that 
the induction of AS mRNA in canavanine- 
resistant cell variants was being controlled in 
the nucleus. To test for this directly, RPMI 
2650 and Cant-1 cells were fractionated into 
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Fig. 1. Estimation of AS mRNA decay rate in parental and canavanine-resistant RPMI 2650 cells. Fifty micrograms 
of total RNA were used in each assay for RPMI 2650 cells and 5 #g were used for Cant-1 cells. The probe was a 
HindlII-EcoRI restriction fragment of the AS cDNA (thin line, 18) cloned into pUC-8 (thick line). The DNA 
fragment was linearized at the HindlII site and Y-end labeled. The length of the protected region is 292 bases. 
Numbers above each lane represent hours after addition of actinomycin D. M, radiolabeled markers, pUC-9 digested 
with MspI. 
nuclear  and cytoplasmic components,  and AS 
R N A  levels were quantified by S1 nuclease 
analysis using either a c D N A  (Fig. 2) or 
intron probe (Fig. 3). The efficiency of the cell 
fract ionation is verified by the complete lack 
of poly(A) + m R N A  sequences in the nuclear  
R N A  fraction (Fig. 2, lane m) and the relative 
paucity of intron sequences in the cytoplasmic 
R N A  fraction (Fig. 3, lane e). 
The c D N A  probe spans several splice 
junct ions and thus protects only fully spliced 
RNAs.  A comparison of total (Fig. 2, lanes a 
and d), cytoplasmic (lanes b and e), and 
nuclear  (lanes c and f) R N A  fractions 
Fig. 2. Cellular fractionation studies quantifying AS RNA levels in RPMI 2650 and Can r- 1 cells. S 1 nuclease assays 
were performed using the cDNA probe described in Fig. 1. T, total cellular RNA; C, cytoplasmic RNA; N, nuclear 
RNA. The (+) indicates poly(A)+ RNA and the ( ) indicates poly(A)- RNA. Fifty micrograms of RNA were used in 
each assay except for the poly(A) § samples in which 5 #g were used and in the nuclear poly(A)- samples in which 25 #g 
were used. 
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Fig. 3. S1 nuclease assays quantifying AS precursor 
RNA using an intron 1 probe. Lanes are the same as in 
Fig. 2. The probe contains a 600-bp BamHI-HindlII 
restriction fragment of intron 1 of the human AS gene 
(19) cloned into pUC-8. The probe was linearized at the 
BamHl site and 3'-end labeled. The protected fragment is 
approximately 600 bp in length. B, BamHl; H, HindlII. 
The solid box represents exon 1 in the natural AS gene. 
revealed that in each case the amount of AS 
R N A  was increased approximately two orders 
of magnitude in canavanine-resistant cells. 
The multiplicity increase is identical when 
cytoplasmic and nuclear R N A  fractions are 
compared between cell lines, suggesting that 
efficiency of R N A  transport to the cytoplasm 
was not involved in this regulation. The 
increased amount of AS R N A  in canavanine- 
resistant cell nuclei demonstrates that cyto- 
plasmic m R N A  decay is not responsible for 
increased AS expression in these cells and 
confirms our conclusion drawn from the 
m R N A  decay experiments (Fig. 1). Both total 
and nuclear R N A  was further fractionated 
into poly(A) + and poly(A)- components by 
chromatography on oligo-dT cellulose, and 
the level of AS R N A  was again quantified in 
each subfraction by S1 nuclease analysis. The 
results show that canavanine-resistant cells 
also contained greatly increased amounts of 
nonpolyadenylated AS R N A  (Fig. 2, lanes h 
vs. 1). A smaller yet significant induction of 
AS RNA was observed in canavanine-resis- 
rant cells when nonpolyadenylated nuclear 
R N A  was examined (lanes j vs. n), showing 
that changes in the concentration of specific 
R N A  in nuclear R N A  subpopulations (in this 
case, fully spliced nuclear nonpolyadenylated 
RNA)  were different than those in the total 
nuclear R N A  pool. Thus, the 200-fold 
increased level of AS m R N A  in canavanine- 
resistant cells is predominantly controlled in 
the nucleus, and the processes of polyadenyl- 
ation and R N A  transport to the cytoplasm are 
not involved. 
These conclusions were verified by com- 
parison of the amount of AS precursor R N A  
in parental and canavanine-resistant cells 
(Fig. 3). Nuclear precursor RNAs  containing 
AS intron sequences were also substantially 
increased in canavanine-resistant cell nuclei 
(Fig. 3, lanes c vs. f). Similar findings were 
obtained using nonpolyadenylated nuclear 
R N A  (lanes j vs. n). Thus, the mechanism 
responsible for high expression of AS m R N A  
in canavanine-resistant cells occurs either at 
the initiation of transcription (and is not 
detectable in these cell lines), during elonga- 
tion of the primary transcript, or at some point 
prior to R N A  polyadenylation and export to 
the cytoplasm. 
Increased Expression of  AS  Gene in 
Canavanine-Resistant Cells due to Domi- 
nant, Positive-Acting Mechanism. It  was of 
interest to determine whether the increased 
expression of AS m R N A  was due to the gain 
of a function in canavanine-resistant cells or 
to the loss of a function in RPMI  2650 cells. 
The results from such studies would deter- 
mine whether or not the canavanine-resistant 
phenotype is dominant and whether genomic 
D N A  transfection would be a feasible means 
of cloning trans-acting loci that activate AS 
gene expression. We addressed this question 
by constructing intraspecific somatic cell 
hybrids between R P M I  2650 cells and cana- 
vanine-resistant cell variants. Distinct domi- 
nant selectable markers were introduced into 
each parental cell line to allow for specific 
selection of the hybrid progeny following 
fusion. The dominant selectable marker,  
RSVneo (5), was introduced into R P M I  2650 
ceils generating a G418-resistant parental cell 
line, while the dominant selectable marker,  
RSVgpt (5), was introduced into the Cant-1 
cell line making this parent resistant to my- 
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cophenolic acid. Clones from each parental 
cell line were fused in the presence of polyeth- 
ylene glycol and hybrid progeny were selected 
by growth in media containing G418-HAT/ 
M / X  (hypoxanthine, aminopterin, thymidine, 
mycophenolic acid, xanthine) as outlined in 
Fig. 4A. Individual clones surviving this dou- 
ble selection were isolated, grown en masse, 
and DNA and RNA were prepared. Southern 
blot analysis was used to prove that the 
selected progeny of the fusion were true 
hybrids (Fig. 4B). In the example shown, 
genomic DNA from each parent and three 
cloned hybrids was digested with EcoRI and 
probed with RSVcat plasmid sequences. This 
probe was selected because it detects the 
integration pattern of both dominant select- 
able markers and yields distinguishable 
hybridization patterns for each parent (lanes 
a and b). Several of the hybridizing fragments 
seen in the RPMI 2650 parent are due to an 
AS promoter-CAT minigene present in this 
cell line (1). The RPMI 2650 cell parent has 
three informative bands of 3.2 kb, 3.0 kb, and 
2.6 kb (bands 1, 2, and 4) and the Cant-1 cell 
parent has one informative band of 2.8 kb 
(band 3). The hybridization pattern of each of 
the three independently isolated hybrids 
(lanes c-e) was the sum of the parents, con- 
firming that the hybrid cell lines contained 
genetic information from each parent. 
The amount of AS mRNA in each of the 
three hybrid cell lines was compared to the 
parental cell lines using S1 nuclease analysis 
(Fig. 4C). The results show that in each 
hybrid cell line, the amount of AS mRNA was 
approximately equal to the high level found in 
the canavanine-resistant cell parent. Consis- 
tent with this finding is the observation that 
all of the hybrid cell lines expressed the cana- 
vanine-resistant phenotype as demonstrated 
by their ability to grow in media containing 3 
~zM canavanine. These findings indicate that 
high expression of AS mRNA is due to a 
positive-acting mechanism operating in can- 
avanine-resistant cells and not to the loss of a 
trans-acting repressor in RPMI 2650 cells. 
Consistent with our earlier findings (1), 
expression of the CAT minigene was not 
elevated in the hybrid cells when compared to 
the RPMI 2650 cell parent (data not shown). 
This observation confirms our previous con- 
clusion that AS promoter-CAT minigenes are 
not subject to trans-induction in canavanine- 
resistant cells as is the endogenous AS gene. 
DISCUSSION 
The goal of these studies was to charac- 
terize the molecular basis for high expression 
of AS mRNA in canavanine-resistant cell 
variants. Degradation rates of AS mRNA 
were estimated in the presence of actinomycin 
D. In each cell type, the AS mRNA is rela- 
tively stable, with a half-life of 12-24 h. These 
findings show that stabilization of cytoplas- 
mic mRNA is not involved in the induction of 
AS mRNA in canavanine-resistant cells. Cel- 
lular fractionation studies confirm this con- 
clusion. Canavanine-resistant cell nuclei show 
greatly increased amounts of spliced AS RNA 
before RNA polyadenylation and transport to 
the cytoplasm occur. Furthermore, the 
amount of precursor RNA containing AS 
intron sequences is greatly increased in cana- 
vanine-resistant cell nuclei. Therefore, the 
control mechanism must act very early in the 
synthesis or processing of AS precursor RNA. 
An abundant amount of nonpolyadenylated- 
spliced AS RNA was detected in this study 
(Fig. 2). This suggests that splicing of the AS 
primary transcript may precede polyadenyl- 
ation, although inefficient fractionation could 
also give rise to these results (due to short 
poly(A) tails). Our observations are in con- 
trast to previous studies that examined the 
processes of splicing and polyadenylation in 
the SV40 late gene RNAs and adenovirus 2 
RNAs (11, 12). Those studies concluded that 
polyadenylation precedes splicing. The signif- 
icance of this observation is unclear at present 
and is currently being investigated. 
We constructed intraspecific somatic cell 
hybrids between RPMI 2650 cells, which 
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A r 
RSVgpt 
'~~ X ~ HAT/oM/X r 
C select for neo+gpt 
, I ~ 1  ~AS:? 
llTig d tA~ Rtra~,~c,,~ f,~r ,'nn~tr;~t-ti,~n ns ~nrnntic ~11 hvhrid~ tegtin9 for dominance. (B~ Southern blot t~attern of 
parental and hybrid cell lines. Ten micrograms of genomic DNA from each cell line were digested with EcoRI and 
subjected to Southern blot analysis. The probe was radiolabeled RSVcat (20) plasmid DNA. Lane a, RPMI 2650 
parent containing an AS promoter-CAT minigene, pmgAS-10, and RSVneo (1); lane b, Canr-I parent containing 
RSVgpt; lanes c-e, cloned hybrid cell lines C6, B 1, and C 1. (C) S 1 nuclease assays quantifying AS m R N A  expression 
in parental and hybrid cell lines. Fifty micrograms of total RNA were used in each assay. The lanes are the same as in 
B. The probe was the same as in Fig. 1. Below the autoradiogram is a partial restriction map of the AS cDNA. A, AvaI; 
H, HindlII; E, EcoRI, X, Xhol; P, PvulI. 
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express a low level of AS mRNA, and cana- 
vanine-resistant cell variants, which express a 
high level, to determine whether high expres- 
sion of AS mRNA is dominant or recessive. 
All hybrid cell lines contain a high level of AS 
mRNA, implicating a positive-acting mecha- 
nism operating in the canavanine-resistant 
cell. These experiments rule out the possibility 
that the induction of AS mRNA in canavan- 
ine-resistant cells is due to the loss of a 
trans-acting repressor. This assumes that no 
specific loss of chromosomes occurred in the 
human-human cell hybrids. It is important to 
note that the cell fusion studies do not discrim- 
inate between a cis- or trans-acting mecha- 
nism. However, studies using canavanine- 
resistant human lymphoblasts have indicated 
that the induction of AS mRNA in canavan- 
ine-resistant cell variants is due to a trans- 
acting mechanism (1). We feel that the mech- 
anism by which mammalian cells induce A S  
gene expression in canavanine-resistant vari- 
ants is likely to be common among different 
cell types. Consistent with this idea are the 
observations that the multiplicity of induction 
of AS mRNA in canavanine-resistant lym- 
phoblasts and RPMI 2650 cells is similar (200 
to 300-fold) (4, 13). 
Two questions remain unanswered re- 
garding the mechanism underlying high AS 
mRNA expression in canavanine-resistant 
cell variants: (1) whether the mechanism is 
acting at the transcriptional or nuclear post- 
transcriptional level and (2) whether the 
mechanism is activated in the canavanine- 
resistant cell by a genetic or epigenetic event. 
If induction of AS mRNA expression is tran- 
scriptional, the cis-acting element necessary 
for this regulation must exert its effect 
through a great distance. We base this state- 
ment on the findings that AS minigenes con- 
taining genomic sequences 3 kb 5' and 12 kb 3' 
from the transcription initiation site fail to 
express at higher levels in canavanine-resis- 
tant cells as compared to parental RPMI 2650 
cells (1, 2). Furthermore, if the cis-acting 
element is intragenic, it must lie in an intron 
since AS cDNA minigenes also fail to express 
at higher levels in canavanine-resistant cell 
variants (21). It is clear, however, that if the 
mechanism is transcriptional, it must involve 
sequences other than those present in the 
immediate 5' flanking region of the A S  gene. 
All of our data concerning induction of the A S  
gene in canavanine-resistant cells are consis- 
tent with a nuclear posttranscriptional mecha- 
nism. Posttranscriptional control has been 
implicated in the regulation of several genes 
that are expressed abundantly in liver similar 
to AS (9, 14-16). These include genes that are 
expressed exclusively in liver (albumin, phe- 
nylalanine hydroxylase, adolase B, trans- 
ferrin) and those expressed at a high level in 
liver and at low levels in most other nonhe- 
patic tissues (phosphoenolpyruvate carboxy- 
kinase). Thus, induction of A S  gene expres- 
sion in canavanine-resistant cells shares at 
least one characteristic with liver-specific 
gene expression in that high cytoplasmic 
mRNA levels are achieved through a positive- 
acting nuclear mechanism. 
Several observations suggest that the 
mechanism underlying induction of the A S  
gene is activated epigenetically in canavanine- 
resistant cells. For instance, the frequency of 
obtaining canavanine-resistant cell variants is 
not increased when cells are treated with point 
mutagens (ethylmethyl sulfonate), agents 
that alter DNA methylation (5-azacytidine), 
or agents that promote gene amplification 
(tumor promoters and hydroxyurea, unpub- 
lished data). These observations suggest, but 
do not prove, that the mechanism underlying 
high A S  expression is not activated through 
covalent changes in DNA. They also argue 
against the possibility that the A S  gene is 
transcriptionally activated in the canavanine- 
resistant cell by a cis-acting mutation (such as 
a base change in the AS promoter region). 
Interestingly, our observations are consistent 
with those made with dedifferentiated vari- 
ants of rat hepatoma cells that spontaneously 
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reacquire a liver cell-like phenotype in culture 
(17). Preliminary experiments have shown 
that the frequency of isolating canavanine- 
resistant cell variants increases 20- to 50-fold 
above the background frequency following 
genomic DNA transfection (R. Pogulis and S. 
Freytag, unpublished data). The increase in 
frequency is identical when either RPMI 2650 
cell or canavanine-resistant cell genomic 
DNA is used but is substantially higher than 
mock-transfected cells. Taken together, these 
observations suggest that activation of AS 
gene expression is not the result of a genetic 
change in canavanine-resistant cells, but 
instead is consistent with an epigenetic mech- 
anism. Since it is likely that cell differentia- 
tion is controlled epigenetically, we feel these 
observations support our contention that the 
canavanine-resistant cell variant represents a 
more differentiated cell type that has acti- 
vated a mechanism normally used in cell 
differentiation, perhaps one used during liver 
differentiation. Given that the canavanine- 
resistant phenotype is selectable and the 
knowledge that the phenotype is dominant, 
this system provides a powerful means of 
isolating trans-acting loci that induce a differ- 
entiated cell trait. 
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